Access to Innovative Treatments Act of 2023

Summary

Official

Access to Innovative Treatments Act of 2023 This bill requires the Centers for Medicare & Medicaid Services (CMS) to review adverse national coverage determinations of drugs under Medicare within 30 days of receiving a request to do so. (Under the bill, adverse national coverage determinations are denials or limitations of coverage that are inconsistent with the drug's...

How would you vote on this bill?

Yes No

Bill Progress

Bill has been introduced and assigned a number

Introduced(3/30/23)

Committee

Passed House

Passed Senate

President

Law

Sponsor

Ms. Barragán

House (D) California – 44

Cosponsors (1)

Joyce

House (R) Pennsylvania

Topics

Health

Latest Action

Referred to the Subcommittee on Health.

Dec 17, 2024